Penumbra Indigo® Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ACN
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. NVDA

Go back to Penumbra Indigo® Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints
(NYSE: PEN) Delayed: 319.76 -2.41 (0.75%)
Previous Close $322.17    52 Week High $79.49 
Open $322.61    52 Week Low $40.23 
Day High $322.61    P/E N/A 
Day Low $319.74    EPS $0.00 
Volume 188,961